RIBOGENE
RiboGene is a drug discovery company focused on the identification of novel leads and the development of potential drug candidates for the treatment of infectious diseases. The Company's drug discovery efforts target bacterial, fungal and viral infections for which the efficacy of existing therapies is being threatened by the emergence of drug resistance or for which existing therapies have had limited effectiveness. The Company's drug discovery technology is based on the translational control of gene expression.
RIBOGENE
Industry:
Biotechnology Genetics Health Care
Founded:
1989-01-01
Address:
Hayward, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Similar Organizations
BIKAM Pharmaceuticals
BIKAM Pharmaceuticals is a drug discovery company focused on the discovery and development of novel drugs for degenerative diseases.
Zymenex
Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
1994-01-01 | Darby Pharmaceuticals | Darby Pharmaceuticals acquired by RiboGene | 4.4 M USD |